Phase I Study of Oral DFP-11207 in Solid Tumors
NCT02171221
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Cancer
Interventions
DRUG:
Oral DFP-11207
Sponsor
Delta-Fly Pharma, Inc.